Skip to main content
Erschienen in: Osteoporosis International 4/2005

01.04.2005 | Opinion Paper

The need for microsimulation to evaluate osteoporosis interventions

verfasst von: David J. Vanness, Anna N. A. Tosteson, Sherine E. Gabriel, L. Joseph Melton III

Erschienen in: Osteoporosis International | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Simulations play an increasingly important role in the evaluation of osteoporosis interventions. Existing evaluations have been based on “reduced-form” cohort simulations that do not reflect the complexity and heterogeneity of osteoporosis and its outcomes. Such simplified models offer parsimony and ease of use, but they also are limited in their ability to explain and extrapolate outcomes in a way that is most useful for both clinical and health policy decision makers. Alternatively, evaluations could be based on “structural” microsimulations, which explicitly model the underlying biology of osteoporosis at the individual level. The structural approach presents technical challenges, including the need to obtain more-detailed data and the requirement that underlying biological models be validated. However, evaluations based on structural microsimulation may ultimately provide substantially more useful information, resulting in improved decision making.
Literatur
1.
Zurück zum Zitat Osteoporosis Prevention, Diagnosis and Therapy (2000) NIH Consensus Statement 27–29 March 2000 17:1–36 Osteoporosis Prevention, Diagnosis and Therapy (2000) NIH Consensus Statement 27–29 March 2000 17:1–36
2.
Zurück zum Zitat Kanis JA, Jonsson B (2002) Economic evaluation of interventions for osteoporosis. Osteoporos Int 13:765–767 Kanis JA, Jonsson B (2002) Economic evaluation of interventions for osteoporosis. Osteoporos Int 13:765–767
3.
Zurück zum Zitat Zethraeus N, Ben Sedrine W, Caulin F, Corcaud S, Gathon HJ, Haim M, Johnell O, Jonsson B, Kanis JA, Tsouderos Y, Reginster JY (2002) Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis. Osteoporos Int 13:841–857CrossRefPubMed Zethraeus N, Ben Sedrine W, Caulin F, Corcaud S, Gathon HJ, Haim M, Johnell O, Jonsson B, Kanis JA, Tsouderos Y, Reginster JY (2002) Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis. Osteoporos Int 13:841–857CrossRefPubMed
4.
Zurück zum Zitat Clemen RT (1996) Making hard decisions: an introduction to decision analysis, 2nd edn. Duxbury Press, Belmont, CA Clemen RT (1996) Making hard decisions: an introduction to decision analysis, 2nd edn. Duxbury Press, Belmont, CA
5.
Zurück zum Zitat Koopmans TC (1949) Identification problems in economic model construction. Econometrica 17:125–144 Koopmans TC (1949) Identification problems in economic model construction. Econometrica 17:125–144
6.
Zurück zum Zitat Zethraeus N, Johannesson M, Jonsson B (1999) A computer model to analyze the cost-effectiveness of hormone replacement therapy. Int J Technol Assess Health Care 15:352–365PubMed Zethraeus N, Johannesson M, Jonsson B (1999) A computer model to analyze the cost-effectiveness of hormone replacement therapy. Int J Technol Assess Health Care 15:352–365PubMed
7.
Zurück zum Zitat Tosteson ANA, Rosenthal DI, Melton LJ 3rd, Weinstein MC (1990) Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Internal Med 113:594–603 Tosteson ANA, Rosenthal DI, Melton LJ 3rd, Weinstein MC (1990) Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Internal Med 113:594–603
8.
Zurück zum Zitat Cranney A, Coyle D, Welch V, Lee KM, Tugwell P (1999) A review of economic evaluation in osteoporosis. Arthritis Care Res 12:425–434CrossRefPubMed Cranney A, Coyle D, Welch V, Lee KM, Tugwell P (1999) A review of economic evaluation in osteoporosis. Arthritis Care Res 12:425–434CrossRefPubMed
9.
Zurück zum Zitat Heaney RP (1998) Bone mass, bone fragility, and the decision to treat. JAMA 280:2119–2120 Heaney RP (1998) Bone mass, bone fragility, and the decision to treat. JAMA 280:2119–2120
10.
Zurück zum Zitat Turner CH (2002) Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 13:97–104 Turner CH (2002) Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 13:97–104
11.
Zurück zum Zitat Leibson CL, Tosteson ANA, Gabriel SE, Ransom JE, Melton LJ (2002) Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 50:1644–1650 Leibson CL, Tosteson ANA, Gabriel SE, Ransom JE, Melton LJ (2002) Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 50:1644–1650
12.
Zurück zum Zitat Ray NF, Chan JK, Thamer M, Melton LJ 3rd (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35PubMed Ray NF, Chan JK, Thamer M, Melton LJ 3rd (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35PubMed
13.
Zurück zum Zitat Gabriel SE, Tosteson ANA, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330CrossRefPubMed Gabriel SE, Tosteson ANA, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330CrossRefPubMed
14.
Zurück zum Zitat Brazier JE, Green C, Kanis JA (2002) A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int 13:768–776CrossRefPubMed Brazier JE, Green C, Kanis JA (2002) A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int 13:768–776CrossRefPubMed
15.
Zurück zum Zitat Tosteson ANA, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ 3rd (2001) Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 12:1042–1049CrossRefPubMed Tosteson ANA, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ 3rd (2001) Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 12:1042–1049CrossRefPubMed
16.
Zurück zum Zitat Hayes WC, Myers ER, Robinovitch SN, Van Den Kroonenberg A, Courtney AC, McMahon TA (1996) Etiology and prevention of age-related hip fractures. Bone 18:77S-86S Hayes WC, Myers ER, Robinovitch SN, Van Den Kroonenberg A, Courtney AC, McMahon TA (1996) Etiology and prevention of age-related hip fractures. Bone 18:77S-86S
17.
Zurück zum Zitat Robinovitch SN, Hsiao ET, Sandler R, Cortez J, Liu Q, Paiement GD (2000) Prevention of falls and fall-related fractures through biomechanics. Exerc Sport Sci Rev 28:74–79 Robinovitch SN, Hsiao ET, Sandler R, Cortez J, Liu Q, Paiement GD (2000) Prevention of falls and fall-related fractures through biomechanics. Exerc Sport Sci Rev 28:74–79
18.
Zurück zum Zitat Daley MJ, Spinks WL (2000) Exercise, mobility and aging. Sports Med 29:1–12 Daley MJ, Spinks WL (2000) Exercise, mobility and aging. Sports Med 29:1–12
19.
Zurück zum Zitat Gregg EW, Pereira MA, Caspersen CJ (2000) Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc 48:883–893PubMed Gregg EW, Pereira MA, Caspersen CJ (2000) Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc 48:883–893PubMed
20.
Zurück zum Zitat Myers ER, Wilson SE (1997) Biomechanics of osteoporosis and vertebral fracture. Spine 22:25S-31S Myers ER, Wilson SE (1997) Biomechanics of osteoporosis and vertebral fracture. Spine 22:25S-31S
21.
Zurück zum Zitat Grabiner MD, Pavol MJ, Owings TM (2002) Can fall-related hip fractures be prevented by characterizing the biomechanical mechanisms of failed recovery? Endocr J 17:15–20 Grabiner MD, Pavol MJ, Owings TM (2002) Can fall-related hip fractures be prevented by characterizing the biomechanical mechanisms of failed recovery? Endocr J 17:15–20
22.
Zurück zum Zitat Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14 [Suppl 3]:S2–S8 Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14 [Suppl 3]:S2–S8
23.
Zurück zum Zitat Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302CrossRefPubMed Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302CrossRefPubMed
24.
Zurück zum Zitat Frost HM (1966) Bone dynamics in metabolic bone disease. J Bone Joint Surg 48:1192–1203 Frost HM (1966) Bone dynamics in metabolic bone disease. J Bone Joint Surg 48:1192–1203
25.
Zurück zum Zitat Banks J, Carson JS 2nd, Nelson BL, Nicol DM (2000) Discrete-event system simulation, 3rd edn. Prentice Hall, New Jersey Banks J, Carson JS 2nd, Nelson BL, Nicol DM (2000) Discrete-event system simulation, 3rd edn. Prentice Hall, New Jersey
26.
Zurück zum Zitat Parmigiani G (2002) Modeling in medical decision making: a Bayesian approach. John Wiley & Sons, New York Parmigiani G (2002) Modeling in medical decision making: a Bayesian approach. John Wiley & Sons, New York
27.
Zurück zum Zitat Claxton K (1999) Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals. Health Econ 8:269–274CrossRefPubMed Claxton K (1999) Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals. Health Econ 8:269–274CrossRefPubMed
28.
Zurück zum Zitat Riggs BL, Melton LJ 3rd (2002) Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 17:11–14PubMed Riggs BL, Melton LJ 3rd (2002) Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 17:11–14PubMed
29.
Zurück zum Zitat Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082CrossRefPubMed Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082CrossRefPubMed
30.
Zurück zum Zitat Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281–289CrossRefPubMed Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281–289CrossRefPubMed
31.
Zurück zum Zitat Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R (2002) Mulitple outcomes of raloxifene evaluation investigators, efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: 4-year results from a randomized clinical trial. J Clin Endocrinol Metab 87:3609–3617CrossRefPubMed Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R (2002) Mulitple outcomes of raloxifene evaluation investigators, efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: 4-year results from a randomized clinical trial. J Clin Endocrinol Metab 87:3609–3617CrossRefPubMed
32.
Zurück zum Zitat McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY, Hip Intervention Program Study Group (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340CrossRefPubMed McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY, Hip Intervention Program Study Group (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340CrossRefPubMed
33.
Zurück zum Zitat Black DM, Greenspan SL, Ensrud KE (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207–1215CrossRefPubMed Black DM, Greenspan SL, Ensrud KE (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207–1215CrossRefPubMed
34.
Zurück zum Zitat Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) Effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216–1226CrossRefPubMed Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) Effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216–1226CrossRefPubMed
35.
Zurück zum Zitat Khosla S (2003) Parathyroid hormone plys alendronate—a combination that does not add up. N Engl J Med 349:1277–1279 Khosla S (2003) Parathyroid hormone plys alendronate—a combination that does not add up. N Engl J Med 349:1277–1279
36.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258CrossRefPubMed Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258CrossRefPubMed
37.
Zurück zum Zitat J Mullahy (2001) Live long, live well: quantifying the health of heterogeneous populations. Health Econ 10:429–440 J Mullahy (2001) Live long, live well: quantifying the health of heterogeneous populations. Health Econ 10:429–440
38.
Zurück zum Zitat Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M (1997) Modeling in economic evaluation: an unavoidable fact of life. Health Econ 6:217–227 Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M (1997) Modeling in economic evaluation: an unavoidable fact of life. Health Econ 6:217–227
39.
Zurück zum Zitat Kling A, Barao F, Nakagawa M, Tavora L, Vaz P (eds) (2001) Advanced Monte Carlo for radiation physics, particle transport simulation and applications. Springer, Heidelberg Berlin New York Kling A, Barao F, Nakagawa M, Tavora L, Vaz P (eds) (2001) Advanced Monte Carlo for radiation physics, particle transport simulation and applications. Springer, Heidelberg Berlin New York
Metadaten
Titel
The need for microsimulation to evaluate osteoporosis interventions
verfasst von
David J. Vanness
Anna N. A. Tosteson
Sherine E. Gabriel
L. Joseph Melton III
Publikationsdatum
01.04.2005
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 4/2005
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-004-1826-8

Weitere Artikel der Ausgabe 4/2005

Osteoporosis International 4/2005 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.